BAC
- Product NDC
- 43857-0530
- 11-digit product format
- 438570530
- Labeler code
- 43857
- Product ID
- 43857-0530_ffdca3ab-76e7-440e-b1c5-9e93bf2e91c2
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Echinacea (Angustifolia), Lomatium Dissectum, Myrrha, Nasturtium Aquaticum, Tabebuia Impetiginosa, Hydrastis Canadensis, Propolis, Glandula Suprarenalis Suis, Lymph Node (Suis), Spleen (Suis), Thymus (Suis), Thyroidinum (Suis), Arsenicum Album, Belladonna, Hypericum Perforatum, Phosphorus, Botulinum, Escherichia Coli, Proteus (Vulgaris), Pseudomonas Aeruginosa, Proteus (Morgani), Salmonella Typhi Nosode, Clostridium Perfringens
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- BioActive Nutritional, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2019-12-26
- Marketing end
- 2025-05-15
- Substance
- ECHINACEA ANGUSTIFOLIA; LOMATIUM DISSECTUM ROOT; MYRRH; NASTURTIUM OFFICINALE; TABEBUIA IMPETIGINOSA BARK; GOLDENSEAL; PROPOLIS WAX; SUS SCROFA ADRENAL GLAND; SUS SCROFA LYMPH; SUS SCROFA SPLEEN; SUS SCROFA THYMUS; SUS SCROFA THYROID; ARSENIC TRIOXIDE; ATROPA BELLADONNA; HYPERICUM PERFORATUM; PHOSPHORUS; BOTULINUM TOXIN TYPE A; ESCHERICHIA COLI; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; PROTEUS MORGANII; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; CLOSTRIDIUM PERFRINGENS
- Active strength
- 3 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 43857-0530-1 | 43857053001 | 30 mL in 1 BOTTLE, DROPPER (43857-0530-1) | 30 ml | 2019-12-26 | 2025-05-15 | No | No | Current |